Audrey’s MS diagnosis led her down a path of discovery, where she found sophrology. This relaxation technique blends a fusion of yoga, meditation and zen. Find out how sophrology made Audrey's life more meaningful.

Poor sleep is common in people with multiple sclerosis, with about 50% of people with MS reported to experience some form of sleep disturbance. Despite this being well known, sleep disorders are under-diagnosed and under-treated in people with MS.

Patient information paragraphs for disease modifying drugs in childhood MS. POMS DMDs used in the UK.

Jenna talks about her MS diagnosis, pregnancy and the challenge of choosing a new disease modifying drug after giving birth to her son.

Breastfeeding provides long term health benefits for a baby and may reduce the risk of post-pregnancy relapse in some women with MS. MS cannot be passed on through breast milk.

Opicinumab (also known as anti-LINGO-1 and BIIB033) was an experimental drug investigated as a treatment to promote myelin repair in multiple sclerosis. Clinical studies were halted in 2020.

The MS Trust has praised the pioneering work of the MS Risk Sharing Scheme (RSS) as the final results from the scheme are published in the Journal of Neurology, Neurosurgery and Psychiatry today (September 24).

Ocrevus (ocrelizumab) is a disease modifying drug treatment for relapsing remitting and early primary progressive MS. It is taken as an infusion into a vein or an injection under the skin every six months.

Find out how you can use your London Marathon place to run for MS Trust.